News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
217,599 Results
Type
Article (8544)
Company Profile (18)
Press Release (209034)
Multimedia
Podcasts (11)
Webinars (1)
Section
Business (66836)
Career Advice (408)
Deals (12417)
Drug Delivery (26)
Drug Development (28450)
Employer Resources (43)
FDA (4574)
Job Trends (4837)
News (109841)
Policy (8207)
Tag
2027 Pharm Country Standard (1)
Academia (492)
Accelerated approval (21)
Adcomms (3)
Allergies (69)
Alliances (8182)
ALS (98)
Alzheimer's disease (634)
Antibody-drug conjugate (ADC) (207)
Approvals (4920)
Artificial intelligence (272)
Autoimmune disease (129)
Automation (26)
Bankruptcy (89)
Best Places to Work (4416)
BIOSECURE Act (2)
Biosimilars (107)
Biotechnology (14)
Bladder cancer (145)
Brain cancer (33)
Breast cancer (429)
Cancer (3156)
Cardiovascular disease (240)
Career advice (341)
Career pathing (2)
CAR-T (131)
CDC (8)
Cell therapy (372)
Cervical cancer (28)
Clinical research (27328)
Collaboration (886)
Company closure (3)
Compensation (515)
Complete response letters (27)
COVID-19 (807)
CRISPR (55)
C-suite (364)
Cystic fibrosis (73)
Data (4395)
Decentralized trials (1)
Depression (70)
Dermatology (35)
Diabetes (256)
Diagnostics (2202)
Digital health (21)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (129)
Drug pricing (39)
Drug shortages (5)
Duchenne muscular dystrophy (131)
Earnings (56206)
Editorial (6)
Employer branding (8)
Employer resources (35)
Events (40794)
Executive appointments (453)
FDA (6450)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (788)
Gene editing (98)
Generative AI (16)
Gene therapy (296)
GLP-1 (456)
Government (1155)
Grass and pollen (4)
Guidances (361)
Healthcare (5886)
HIV (51)
Huntington's disease (19)
IgA nephropathy (52)
Immunology and inflammation (128)
Immuno-oncology (39)
Indications (80)
Infectious disease (963)
Inflammatory bowel disease (83)
Inflation Reduction Act (3)
Influenza (54)
Intellectual property (108)
Interviews (81)
IPO (7593)
IRA (7)
Job creations (733)
Job search strategy (292)
JPM (12)
Kidney cancer (13)
Labor market (33)
Layoffs (172)
Leadership (6)
Legal (1522)
Liver cancer (37)
Longevity (9)
Lung cancer (448)
Lymphoma (278)
Machine learning (29)
Management (11)
Manufacturing (325)
MASH (94)
Medical device (4211)
Medtech (4248)
Mergers & acquisitions (5484)
Metabolic disorders (670)
mRNA (36)
Multiple sclerosis (87)
NASH (8)
Neurodegenerative disease (165)
Neuropsychiatric disorders (45)
Neuroscience (1304)
NextGen: Class of 2026 (1439)
Non-profit (952)
Now hiring (12)
Obesity (302)
Opinion (50)
Ovarian cancer (119)
Pain (118)
Pancreatic cancer (124)
Parkinson's disease (147)
Partnered (4)
Patents (223)
Patient recruitment (242)
Peanut (26)
People (7512)
Pharmaceutical (7)
Pharmacy benefit managers (8)
Phase 1 (7391)
Phase 2 (11672)
Phase 3 (10452)
Pipeline (4608)
Policy (31)
Postmarket research (1009)
Preclinical (2541)
Press Release (12)
Prostate cancer (179)
Psychedelics (13)
Radiopharmaceuticals (99)
Rare diseases (470)
Real estate (907)
Recruiting (23)
Regulatory (7649)
Reports (20)
Research institute (485)
Resumes & cover letters (58)
Rett syndrome (25)
RNA editing (7)
RSV (44)
Schizophrenia (93)
Series A (116)
Series B (91)
Sickle cell disease (52)
Special edition (9)
Spinal muscular atrophy (52)
Sponsored (4)
Startups (616)
State (1)
Stomach cancer (6)
Supply chain (48)
Tariffs (17)
The Weekly (10)
Vaccines (396)
Venture capital (41)
Weight loss (192)
Women's health (57)
Worklife (6)
Date
Today (114)
Last 7 days (393)
Last 30 days (1534)
Last 365 days (17023)
2026 (4092)
2025 (17255)
2024 (15672)
2023 (15118)
2022 (18166)
2021 (18192)
2020 (16426)
2019 (13467)
2018 (9720)
2017 (9609)
2016 (8552)
2015 (10865)
2014 (8031)
2013 (5966)
2012 (6452)
2011 (6731)
2010 (5946)
Location
Africa (174)
Alabama (39)
Alaska (2)
Arizona (79)
Arkansas (7)
Asia (13284)
Australia (1921)
California (6955)
Canada (1543)
China (589)
Colorado (264)
Connecticut (321)
Delaware (260)
Europe (30500)
Florida (862)
Georgia (185)
Hawaii (3)
Idaho (13)
Illinois (516)
India (28)
Indiana (294)
Iowa (9)
Japan (337)
Kansas (43)
Kentucky (20)
Louisiana (25)
Maine (52)
Maryland (643)
Massachusetts (5096)
Michigan (142)
Minnesota (326)
Mississippi (3)
Missouri (69)
Montana (8)
Nebraska (4)
Nevada (95)
New Hampshire (35)
New Jersey (2048)
New Mexico (13)
New York (1652)
North Carolina (746)
North Dakota (3)
Northern California (3519)
Ohio (144)
Oklahoma (6)
Oregon (14)
Pennsylvania (1217)
Puerto Rico (7)
Rhode Island (17)
South America (289)
South Carolina (18)
Southern California (2630)
Tennessee (85)
Texas (1038)
United States (23649)
Utah (210)
Virginia (186)
Washington D.C. (33)
Washington State (600)
West Virginia (1)
Wisconsin (99)
217,599 Results for "8".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mesoblast to Host R&D Day on April 8, 2026
March 18, 2026
·
5 min read
Press Releases
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares
January 19, 2026
·
5 min read
Press Releases
ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026
March 25, 2026
·
5 min read
Press Releases
BioXcel Therapeutics Announces Closing of $8.0 Million Registered Direct Offering
March 12, 2026
·
5 min read
Press Releases
BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering
March 10, 2026
·
5 min read
Press Releases
Egetis Announces FDA Acceptance and Priority Review of NDA for Emcitate(R) (tiratricol) for MCT8 Deficiency
March 30, 2026
·
4 min read
Press Releases
Moleculin Announces Exercise of Warrants for $8.3 Million Gross Proceeds
February 19, 2026
·
5 min read
Press Releases
Egetis Receives Notice of Allowance for MCT8 Deficiency Composition Patent in the U.S.
March 9, 2026
·
4 min read
Press Releases
Semarion Secures $3.8 Million to Scale Next-Generation Cell Assay Technology and Accelerate Pharma Adoption
March 31, 2026
·
3 min read
Mergers & acquisitions
Gilead Doubles Down on CAR T With $7.8B Arcellx Acquisition
The centerpiece of the takeover is anito-cel, a CAR T therapy under development for relapsed or refractory multiple myeloma. An FDA decision on the therapy is expected by December 2026.
February 23, 2026
·
2 min read
·
Tristan Manalac
1 of 21,760
Next
